Abstract
Advanced glycation irreversibly and progressively modifies proteins over time and yields the advanced glycation end-products (AGE). AGEs are thought to contribute to the development of atherosclerosis and of diabetic and uremic complications. Their inhibition has thus become a therapeutic goal. In this article, we discuss the role of various reactive carbonyl compound (RCOs) in the genesis of AGEs, postulate the existence of "carbonyl stress" in complicated diabetes and, finally, discuss therapeutic perspective.
Original language | English |
---|---|
Pages (from-to) | 1150-1158 |
Number of pages | 9 |
Journal | Clinical Chemistry and Laboratory Medicine |
Volume | 41 |
Issue number | 9 |
DOIs | |
Publication status | Published - 2003 Oct 27 |
Externally published | Yes |
Keywords
- Advanced glycosylation end-products
- Carbonyl stress
- Diabetes mellitus
- Oxidative stress
ASJC Scopus subject areas
- Clinical Biochemistry
- Biochemistry, medical